Want to see AIFA full AI Analyst Report?
All In FutureTech Alliance (AIFA) Risk Analysis
Risk Overview Q2, 2026
Source: the company's latest filing for the period ended Jun 30, 2026, filed Aug 14, 2026
Risk Change Over Time
- Share Price & Shareholder Rights - Risk 1Our recently completed 1-for-6 reverse stock split may not enable us to regain or maintain compliance with Nasdaq listing requirements and may adversely affect the market price and liquidity of our common stock.
On June 11, 2026, the Company effected a 1-for-6 reverse stock split of its common stock, which became effective at 5:01 p.m. Eastern Time. Trading of the Company's common stock on a split-adjusted basis commenced on June 12, 2026. The reverse stock split was implemented as part of the Company's efforts to regain compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share, and to support the Company's continued listing on The Nasdaq Capital Market. The reverse stock split does not itself result in compliance with Nasdaq's minimum bid price requirement. The Company must continue to satisfy Nasdaq's continued listing standards, including maintaining a minimum closing bid price of at least $1.00 per share for the period required by Nasdaq. There can be no assurance that the market price of the Company's common stock will remain above such threshold following the reverse stock split or that Nasdaq will determine that the Company has regained compliance with applicable listing standards. There can be no assurance that the reverse stock split will result in a sustained increase in the market price of the Company's common stock, improve investor confidence, increase trading activity, or otherwise enable the Company to regain or maintain compliance with Nasdaq's continued listing standards. The market price of the Company's common stock may decline following the reverse stock split, and any increase resulting from the reverse stock split may not be proportional to the reduction in the number of outstanding shares. In addition, the reverse stock split may reduce the liquidity of the Company's common stock, increase share price volatility, discourage certain investors from purchasing or holding the Company's common stock, increase transaction costs for stockholders, and adversely affect overall market perception of the Company. Although the Company believes that the reverse stock split may assist in its efforts to regain compliance with Nasdaq listing requirements, the Company may be required to undertake additional actions to regain or maintain compliance with Nasdaq's continued listing standards. If the reverse stock split does not achieve its intended purpose, or if the Company is otherwise unable to regain or maintain compliance with Nasdaq listing requirements, the Company may remain subject to delisting proceedings, which could materially and adversely affect the Company's business, financial condition, results of operations, prospects and ability to raise additional capital.
- Share Price & Shareholder Rights - Risk 2We have received a Nasdaq Staff determination to delist our common stock and there can be no assurance that our common stock will continue to be listed on Nasdaq. Our continued eligibility for listing on The Nasdaq Capital Market depends upon our compliance with Nasdaq's continued listing standards.
On May 6, 2026, the Company received a notice from the Listing Qualifications Department of The Nasdaq Stock Market notifying the Company that Nasdaq had determined to delist the Company's common stock. The Staff determination was based on the Company's failure to regain compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share, during the applicable compliance period, as well as the Company's failure to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2025. Subsequently, on May 19, 2026, the Company received an additional notice from Nasdaq stating that the Company's failure to timely file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2026 constituted an additional basis for delisting under Nasdaq Listing Rule 5250(c)(1). Although the Company subsequently filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2025, and is filing the Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, the Company remains subject to Nasdaq's review process and continues to work to regain compliance with the minimum bid price requirement The Company timely requested a hearing before a Nasdaq Hearings Panel. While the hearing request may stay any immediate suspension or delisting action pending the Panel's decision, there can be no assurance that the Panel will grant the Company's request for continued listing, permit additional time to regain compliance, or determine that the Company has adequately demonstrated its ability to satisfy Nasdaq's continued listing standards. The Company has implemented, or is in the process of implementing, various corrective measures intended to regain compliance, including the filing of its Annual Report on Form 10-K, for the fiscal year ended December 31, 2025, the filing of its Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, the approval and implementation of a 1-for-6 reverse stock split, and other corporate actions. However, there can be no assurance that such efforts will be successful or that the Company will regain compliance within any period permitted by Nasdaq. If the Company's common stock is delisted from Nasdaq, the Company and its stockholders could face significant adverse consequences, including reduced liquidity and marketability of the Company's common stock, increased volatility in the trading price of the Company's common stock, reduced analyst coverage, diminished access to the capital markets, increased difficulty obtaining financing, reduced attractiveness to strategic investors and business partners, and a potential determination that the Company's common stock constitutes a "penny stock." Any such delisting could materially and adversely affect the Company's business, financial condition, results of operations, prospects and ability to execute its strategic objectives.